| Drug Name: | Canakinumab (914613-48-2) |
|---|---|
| PubChem ID: | 124081189 |
| SMILES: | CC1=C(C2=CC=CC=C2C(=C1CCC(C)CCCC(C)CCCC(C)CCCC(C)CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)O)O |
| InchiKey: | WAYNJFGKYDMTCW-PSEKESAWSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 659.096 |
| LogP | : | 14.74672 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 40.46 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category